ストックスクリーナーアプリを入手
60.26
1.81%
-1.3143
前日終値:
$61.57
開ける：
$60.59
24時間の取引高:
864.21K
Relative Volume:
0.84
時価総額：
$4.98B
収益：
-
当期純損益:
$-64.16M
株価収益率:
-47.44
EPS:
-1.2702
ネットキャッシュフロー:
$-69.06M
1週間 パフォーマンス:
+7.75%
1か月 パフォーマンス:
+22.88%
6か月 パフォーマンス:
+82.82%
1年 パフォーマンス:
+125.33%
1日の値動き範囲:
$60.10
$62.11
1週間の範囲:
$55.50
$63.58
52週間の値動き範囲:
$14.80
$63.58
Cg Oncology Inc Stock (CGON) Company Profile
Compare CGON vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
60.24 | 5.09B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.36 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
724.67 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.19 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.66 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-11 | 開始されました | Wedbush | Outperform |
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2025-05-02 | 開始されました | JP Morgan | Overweight |
| 2025-04-16 | 開始されました | Scotiabank | Sector Perform |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-09-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2024-06-28 | 開始されました | BofA Securities | Buy |
| 2024-02-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 開始されました | Goldman | Neutral |
| 2024-02-20 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-14 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cg Oncology Inc (CGON) 最新ニュース
Rafferty Asset Management LLC Lowers Stock Position in CG Oncology, Inc. $CGON - MarketBeat
Tech Rally: Will CG Oncology Inc stock recover after earningsInsider Buying & Risk Managed Investment Strategies - baoquankhu1.vn
Stock Traders Buy High Volume of Call Options on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. $CGON Stock Holdings Trimmed by TD Asset Management Inc - MarketBeat
Lifesci Capital Predicts Stronger Earnings for CG Oncology - MarketBeat
CG Oncology (NASDAQ:CGON) Sets New 12-Month HighTime to Buy? - MarketBeat
CG Oncology, Inc. (CGON) Stock Analysis: A 39% Potential Upside in the Battle Against Bladder Cancer - DirectorsTalk Interviews
CG Oncology stock hits all-time high at 60.01 USD By Investing.com - Investing.com Australia
CG Oncology stock hits all-time high at 60.01 USD - Investing.com
CG Oncology (CGON) Valuation Check As Bladder Cancer Trial Timelines Accelerate And Cash Runway Extends To 2029 - Sahm
NMIBC Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Ferring Pharmaceuticals, FKD Therapies Oy, ImmunityBio, CG Oncology, Pfizer, UroGen Pharma, Janssen R&D - StreetInsider
CGON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Buy Rating on CG Oncology Driven by PIVOT-006 Differentiation and 2026 Clinical, Regulatory Catalysts Supporting Favorable Risk–Reward - TipRanks
CGON: Credo shows high efficacy and durability, with regulatory and commercial plans advancing - TradingView
H.C. Wainwright raises CG Oncology stock price target to $80 By Investing.com - Investing.com Canada
H.C. Wainwright raises CG Oncology stock price target to $80 - Investing.com
AI Stocks: What is the dividend yield of CG Oncology IncJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Vanguard Group Inc. Has $264.93 Million Stock Position in CG Oncology, Inc. $CGON - MarketBeat
The Bull Case For CG Oncology (CGON) Could Change Following Surging Revenue And Deeper 2025 Losses – Learn Why - simplywall.st
What Analysts Are Saying About CG Oncology Stock - Benzinga
HC Wainwright Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
CGON Stock: HC Wainwright & Co. Maintains Rating, Raises Price T - GuruFocus
Why CG Oncology Stock Is Suddenly Surging Higher - TipRanks
CG Oncology (NASDAQ:CGON) Trading Up 5.6% Following Strong Earnings - MarketBeat
CG Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CG Oncology Q4 Net Loss Widens; Expects Cash Runway Into 2029 - marketscreener.com
CG Oncology, Inc. SEC 10-K Report - TradingView
CGON: Net loss rose to $161M as R&D and G&A costs increased; $742M cash on hand funds 12+ months - TradingView
CG Oncology (CGON) builds late-stage bladder cancer franchise on cretostimogene - Stock Titan
CGON: 2025 net loss widened to $161M as R&D ramped up, with $903M cash to fund operations into 2029 - TradingView
CG Oncology (NASDAQ: CGON) widens 2025 loss but secures $903M cash and nears Phase 3 data - Stock Titan
CG Oncology Reports Strong Cash Position and Upcoming Milestones for Cretostimogene Development in NMIBC Trials - Quiver Quantitative
Earnings Flash (CGON) CG Oncology Posts 2025 Total Revenue $4M, vs. FactSet Est of $2.8M - marketscreener.com
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates - The Manila Times
CG Oncology lines up 2026 NMIBC trial readouts with $903M cash - Stock Titan
According to the latest financial data from CG Oncology Inc., the company currently holds a total of $903 millions in cash, cash equivalents, and marketable securities. - Bitget
CG Oncology, Inc. unveils five cretostimogene research posters at ASCO GU in San Francisco - Traders Union
CG Oncology (NASDAQ:CGON) Sets New 52-Week HighTime to Buy? - MarketBeat
CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 36.95% Upside in the Biotech Sector - DirectorsTalk Interviews
JP Morgan Initiates Coverage of CG Oncology (CGON) with Overweight Recommendation - MSN
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference - The Manila Times
CG Oncology leaders at TD Cowen health conference, webcast March 2 - Stock Titan
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
CG Oncology stock hits all-time high at 57.92 USD By Investing.com - Investing.com India
Analysts Are Bullish on These Healthcare Stocks: CG Oncology, Inc. (CGON), Qiagen (QGEN) - The Globe and Mail
CG Oncology (NASDAQ:CGON) Hits New 12-Month HighHere's Why - MarketBeat
What are CG Oncology Inc.’s technical support levels2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
CG Oncology stock hits all-time high at 57.92 USD - Investing.com South Africa
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - Yahoo Finance
Muscle Invasive Bladder Cancer Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | CG Oncology, Pfizer, UroGen Pharma, Janssen R&D, Protara Therapeutics, Binhui Biopharmaceutical - Barchart.com
CenterBook Partners LP Has $15.92 Million Stake in CG Oncology, Inc. $CGON - MarketBeat
Cg Oncology Inc (CGON) 財務データ
収益
当期純利益
現金流量
EPS
4.35%
大文字化:
|
ボリューム (24 時間):